Your browser doesn't support javascript.
loading
Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiation.
Wu, Chengsheng; Weis, Sara M; Cheresh, David A.
Afiliação
  • Wu C; Department of Pathology, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.
  • Weis SM; Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92037, USA.
  • Cheresh DA; Department of Pathology, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.
J Cell Sci ; 136(20)2023 10 15.
Article em En | MEDLINE | ID: mdl-37870164
ABSTRACT
Tumor initiation at either primary or metastatic sites is an inefficient process in which tumor cells must fulfill a series of conditions. One critical condition involves the ability of individual tumor-initiating cells to overcome 'isolation stress', enabling them to survive within harsh isolating microenvironments that can feature nutrient stress, hypoxia, oxidative stress and the absence of a proper extracellular matrix (ECM). In response to isolation stress, tumor cells can exploit various adaptive strategies to develop stress tolerance and gain stemness features. In this Opinion, we discuss how strategies such as the induction of certain cell surface receptors and deposition of ECM proteins enable tumor cells to endure isolation stress, thereby gaining tumor-initiating potential. As examples, we highlight recent findings from our group demonstrating how exposure of tumor cells to isolation stress upregulates the G-protein-coupled receptor lysophosphatidic acid receptor 4 (LPAR4), its downstream target fibronectin and two fibronectin-binding integrins, α5ß1 and αvß3. These responses create a fibronectin-rich niche for tumor cells, ultimately driving stress tolerance, cancer stemness and tumor initiation. We suggest that approaches to prevent cancer cells from adapting to stress by suppressing LPAR4 induction, blocking its downstream signaling or disrupting fibronectin-integrin interactions hold promise as potential strategies for cancer treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Integrinas / Fibronectinas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Integrinas / Fibronectinas Idioma: En Ano de publicação: 2023 Tipo de documento: Article